BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 38353615)

  • 21. Quantitative differences in CD45 expression unmask functions for CD45 in B-cell development, tolerance, and survival.
    Zikherman J; Doan K; Parameswaran R; Raschke W; Weiss A
    Proc Natl Acad Sci U S A; 2012 Jan; 109(1):E3-12. PubMed ID: 22135465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Specific antigen-binding and antibody-secreting lymphocytes associated with the erythrocyte autoantibody responses of NZB and genetically unrelated mice.
    DeHeer DH; Edgington TS
    J Immunol; 1976 Apr; 116(4):1051-8. PubMed ID: 1082901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Developmental partitioning of SYK and ZAP70 prevents autoimmunity and cancer.
    Sadras T; Martin M; Kume K; Robinson ME; Saravanakumar S; Lenz G; Chen Z; Song JY; Siddiqi T; Oksa L; Knapp AM; Cutler J; Cosgun KN; Klemm L; Ecker V; Winchester J; Ghergus D; Soulas-Sprauel P; Kiefer F; Heisterkamp N; Pandey A; Ngo V; Wang L; Jumaa H; Buchner M; Ruland J; Chan WC; Meffre E; Martin T; Müschen M
    Mol Cell; 2021 May; 81(10):2094-2111.e9. PubMed ID: 33878293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Actin-binding protein 1 links B-cell antigen receptors to negative signaling pathways.
    Seeley-Fallen MK; Liu LJ; Shapiro MR; Onabajo OO; Palaniyandi S; Zhu X; Tan TH; Upadhyaya A; Song W
    Proc Natl Acad Sci U S A; 2014 Jul; 111(27):9881-6. PubMed ID: 24958882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T and B cell tolerance and responses to viral antigens in transgenic mice: implications for the pathogenesis of autoimmune versus immunopathological disease.
    Zinkernagel RM; Pircher HP; Ohashi P; Oehen S; Odermatt B; Mak T; Arnheiter H; Bürki K; Hengartner H
    Immunol Rev; 1991 Aug; 122():133-71. PubMed ID: 1937540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. B cell tolerance and antibody production to the celiac disease autoantigen transglutaminase 2.
    du Pré MF; Blazevski J; Dewan AE; Stamnaes J; Kanduri C; Sandve GK; Johannesen MK; Lindstad CB; Hnida K; Fugger L; Melino G; Qiao SW; Sollid LM
    J Exp Med; 2020 Feb; 217(2):. PubMed ID: 31727780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Src homology 2 domain-containing protein-tyrosine phosphatases, SHP-1 and SHP-2, are required for platelet endothelial cell adhesion molecule-1/CD31-mediated inhibitory signaling.
    Henshall TL; Jones KL; Wilkinson R; Jackson DE
    J Immunol; 2001 Mar; 166(5):3098-106. PubMed ID: 11207261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monophosphorylation of CD79a and CD79b ITAM motifs initiates a SHIP-1 phosphatase-mediated inhibitory signaling cascade required for B cell anergy.
    O'Neill SK; Getahun A; Gauld SB; Merrell KT; Tamir I; Smith MJ; Dal Porto JM; Li QZ; Cambier JC
    Immunity; 2011 Nov; 35(5):746-56. PubMed ID: 22078222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impaired B cell function during viral infections due to PTEN-mediated inhibition of the PI3K pathway.
    Getahun A; Wemlinger SM; Rudra P; Santiago ML; van Dyk LF; Cambier JC
    J Exp Med; 2017 Apr; 214(4):931-941. PubMed ID: 28341640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Partial tolerance of autoreactive B and T cells to erythrocyte-specific self-antigens in mice.
    Hudson KE; Hendrickson JE; Cadwell CM; Iwakoshi NN; Zimring JC
    Haematologica; 2012 Dec; 97(12):1836-44. PubMed ID: 22733018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autoreactive B cells recruited to lungs by silica exposure contribute to local autoantibody production in autoimmune-prone BXSB and B cell receptor transgenic mice.
    Fee L; Kumar A; Tighe RM; Foster MH
    Front Immunol; 2022; 13():933360. PubMed ID: 35983030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Repression of B7.2 on self-reactive B cells is essential to prevent proliferation and allow Fas-mediated deletion by CD4(+) T cells.
    Rathmell JC; Fournier S; Weintraub BC; Allison JP; Goodnow CC
    J Exp Med; 1998 Aug; 188(4):651-9. PubMed ID: 9705947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TRAF3 Acts as a Checkpoint of B Cell Receptor Signaling to Control Antibody Class Switch Recombination and Anergy.
    Chen Z; Krinsky A; Woolaver RA; Wang X; Chen SMY; Popolizio V; Xie P; Wang JH
    J Immunol; 2020 Aug; 205(3):830-841. PubMed ID: 32591397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. B Cell Receptor Signaling.
    Tanaka S; Baba Y
    Adv Exp Med Biol; 2020; 1254():23-36. PubMed ID: 32323266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Signaling mechanisms regulating B-lymphocyte activation and tolerance.
    Hobeika E; Nielsen PJ; Medgyesi D
    J Mol Med (Berl); 2015 Feb; 93(2):143-58. PubMed ID: 25627575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peripheral Tolerance Checkpoints Imposed by Ubiquitous Antigen Expression Limit Antigen-Specific B Cell Responses under Strongly Immunogenic Conditions.
    Brooks JF; Murphy PR; Barber JEM; Wells JW; Steptoe RJ
    J Immunol; 2020 Sep; 205(5):1239-1247. PubMed ID: 32709661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pivotal advance: CEACAM1 is a negative coreceptor for the B cell receptor and promotes CD19-mediated adhesion of B cells in a PI3K-dependent manner.
    Lobo EO; Zhang Z; Shively JE
    J Leukoc Biol; 2009 Aug; 86(2):205-18. PubMed ID: 19454653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heterologous regulation of chemokine receptor signaling by the lipid phosphatase SHIP in lymphocytes.
    Wain CM; Westwick J; Ward SG
    Cell Signal; 2005 Oct; 17(10):1194-202. PubMed ID: 16038794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Attenuation of phosphoinositide 3-kinase δ signaling restrains autoimmune disease.
    Maxwell MJ; Tsantikos E; Kong AM; Vanhaesebroeck B; Tarlinton DM; Hibbs ML
    J Autoimmun; 2012 Jun; 38(4):381-91. PubMed ID: 22537464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Precision B Cell-Targeted Therapeutic Approach to Autoimmunity Caused by Phosphatidylinositol 3-Kinase Pathway Dysregulation.
    Franks SE; Getahun A; Cambier JC
    J Immunol; 2019 Jun; 202(12):3381-3393. PubMed ID: 31076529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.